Latest Ratings for ED Date Firm Action From To Mar 2022 Mizuho Maintains Buy Feb 2022 Wolfe Research Upgrades Underperform Peer Perform Jan 2022 Wells Fargo Maintains Equal-Weight View More Analyst Ratings for ED View the Latest Analyst Ratings read more
Latest Ratings for PG Date Firm Action From To Jan 2022 RBC Capital Maintains Sector Perform Jan 2022 Deutsche Bank Maintains Buy Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for PG View the Latest Analyst Ratings read more
Latest Ratings for AMH Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Keybanc Initiates Coverage On Sector Weight Jan 2022 Mizuho Maintains Buy View More Analyst Ratings for AMH View the Latest Analyst Ratings read more
Latest Ratings for AMN Date Firm Action From To Feb 2022 Jefferies Maintains Buy Feb 2022 Benchmark Maintains Buy Nov 2021 Credit Suisse Maintains Outperform View More Analyst Ratings for AMN View the Latest Analyst Ratings read more
JP Morgan upgrades Amneal Pharmaceuticals, citing strong Crexont sales, robust generics growth, and a higher 2025 revenue forecast, with peak sales over $300 million. Latest Ratings for AMRX Date Firm Action From To Mar 2021 Goldman Sachs Upgrades Sell Buy Dec 2020 Guggenheim Upgrades Neutral Buy Nov 2020 SVB Leerink Maintains Market Perform View More…
Intel launched new Xeon 6 processors with performance cores for AI and efficient computing. AMD gaining market share and Intel stock down 43%. read more
Shares of Constellation Energy (CEG) may be forming a new downtrend. The stock has broken an important support level. read more